SCHEMBL20205307

SCHEMBL20205307

CC1(C)c2cc3c(cc2-c2c1cc(-c1ccccc1)c1c2oc2ccccc21)C(C)(C)c1cc(-c2ccccc2)c2c(oc4ccccc42)c1-3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.39
▸ CDC14A Q9UNH5 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.35
▸ PGR P06401 1/20 0.35
▸ CYP1B1 Q16678 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ TNKS O95271 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205313 0.97 CDC14B (0.38) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL20205320 0.96 CDC14B (0.37) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL20205741 0.94 CDC14B (0.36) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL20205527 0.94 CDC14B (0.39) CDC14BCDC14APGRCYP1B1MAPT
SCHEMBL20205310 0.94 CDC14B (0.37) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL20205319 0.94 CDC14B (0.34) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL20205309 0.92 PLA2G2A (0.36) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL23600169 0.92 CDC14B (0.38) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL20205335 0.90 CDC14B (0.40) CDC14BCDC14AALDH1A1PGRCYP1B1
SCHEMBL24649891 0.90 CDC14B (0.37) CDC14BCDC14APGRCYP1B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND CDC14B 3977/4885CDC14A 4435/4885ALDH1A1 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback